Immune responses and Lassa virus infection.

Immune responses and Lassa virus infection.

Item
http://www.wikidata.org/entity/Q38064284
Type I interferon is a therapeutic target for virus-induced lethal vascular damage.Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaquesHighly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever.Vaccine Platforms to Control Arenaviral Hemorrhagic FeversActivation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.Vaccine platforms to control Lassa fever.Determining Ribavirin's mechanism of action against Lassa virus infection.Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever.Axl can serve as entry factor for Lassa virus depending on the functional glycosylation of dystroglycan.Current research for a vaccine against Lassa hemorrhagic fever virus
P2860

Immune responses and Lassa virus infection.

Item
http://www.wikidata.org/entity/Q38064284
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Immune responses and Lassa virus infection.
@en
type
label
Immune responses and Lassa virus infection.
@en
prefLabel
Immune responses and Lassa virus infection.
@en
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P433
P478
P50
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
Immune responses and Lassa virus infection.
@en
P2093
P275
P2860
P304
P31
P356
P433
P478
P50
P5008
P577
P5875
P698
P921
P932